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What Causes Down Syndrome?
Emine Ikbal Atli
Abstract
Trisomy 21 (Down Syndrome) is the model human phenotype for all genome 
gain-dosage imbalance situations, including microduplications. Years after the 
sequencing of chromosome 21, the discovery of functional genomics and the 
creation of multiple cellular and mouse models provided an unprecedented oppor-
tunity to demonstrate the molecular consequences of genome dosage imbalance. 
It was stated years ago that Down syndrome, caused by meiotic separation of 
chromosome 21 in humans, is associated with advanced maternal age, but defining 
and understanding other risk factors is insufficient. Commonly referred to as Down 
syndrome (DS) in humans, trisomy 21 is the most cited genetic cause of mental 
retardation. In about 95% of cases, the extra chromosome occurs as a result of mei-
otic non- nondisjunction (NDJ) or abnormal separation of chromosomes. In most 
of these cases the error occurs during maternal oogenesis, especially in meiosis I.
Keywords: trisomy 21, chromosome 21, non- nondisjunction, down syndrome, 
genetics
1. Introduction
More than 50 years have passed since trisomy 21 was identified as the cause of 
Down syndrome. After that date, the first link between a clinical disorder and a 
chromosomal abnormality was established. In the intervening half century, the 
importance of numerical chromosome abnormalities for human disease pathology 
has been well established.
Studies with live births in the 1960s and 1970s showed that about 0,3% of 
newborns were trisomic or monosomic, while subsequent studies of spontaneous 
abortions found a much higher incidence of about 35%. Taken together, these stud-
ies revealed aneuploidy as the leading known cause of congenital birth defects and 
miscarriages, showing that most cases of aneuploidy disappear in utero [1–3].
In humans, trisomy 21, commonly referred to as Down syndrome (DS), is the 
most common genetic cause of mental retardation. In about 95% of cases, the 
excess chromosome occurs as a result of meiotic nondisjunction (NDJ) or incorrect 
dissociation of chromosomes [4, 5]. In most of the cases, the error occurs during 
maternal oogenesis, especially in meiosis I (MI) [6]. Advanced maternal age and 
defective recombination are two risk factors that have been reported to be associ-
ated with DS for cases where extra chromosome arises in the oocyte. The process 
of oogenesis is long and is a cycle that involves meiotic arrest, making it more 
vulnerable to improper assembly of chromosomes than spermatogenesis. Also, with 
increasing age, there is a rapid degradation of spindle thread formation in sister 
chromatid cohesion or anaphase separation of sister chromatids in oocytes, and this 
poses the risk of NDJ in both MI and MII [7–11].
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Through recombinant DNA technology, a new technique has become available 
to study the origin and mechanisms of chromosomal abnormalities using DNA 
polymorphism analysis. Initially, such analyzes used chromosome 21-specific DNA 
probes to detect restriction fragment length polymorphisms. The development 
of the polymerase chain reaction (PCR) amplification technique has enabled the 
identification of new and highly informative classes of DNA polymorphisms (mic-
rosatellites or simple sequence repeat (SSR) polymorphisms) in the human genome. 
In particular, multi-allelic and easily typeable micro satellites have contributed to 
chromosomal nondisjunction studies in recent years [12–14].
Meiotic meiosis I or II examination of nondisjunction in trisomy 21 by DNA 
polymorphism analysis could not be performed due to the absence of centromeric 
markers. Alphaid DNA polymorphisms specific to the human chromosome 21 
centromere were identified years ago, but these markers were unlikely to provide 
information on the process and were not useful for routine nondisjunction studies. 
However, alfoid DNA polymorphisms were localized in the genetic linkage map 
of chromosome 21(Figure 1), and an estimate of the genetic distance between the 
centromere and the closest pericentromeric markers on the long arm of chromo-
some 21 was made [4, 9, 15].
Two large collaborative studies used DNA polymorphism involving the long arm 
of human chromosome 21 to determine the parental origin of separation in trisomy 
21. Such studies estimate that only 5% of trisomy 21 (of a total of 304 families stud-
ied) originates from the father and attributes the difference in cytogenetic studies 
to the increased accuracy of DNA polymorphism analysis as shown by inaccurate 
Figure 1. 
Short tandem repeat (STR) markers used to infer the origin of the meiotic error and characterization of the 
recombination profile [18].
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cytogenetic determinations in a subgroup of families. Other population-based stud-
ies show paternal meiotic errors in the 5–9% range [16, 17].
For example, the absence of detectable recombination or just a single telomeric 
change may be associated with MI NDJ errors, and this pattern is more common 
in the younger maternal age group than in the older maternal group. In contrast, it 
shows that MII errors are clearly associated with pericentromeric changes in older 
maternal age groups [19].
A molecular study found high differences in mean maternal ages between 
maternal origin cases and paternal origin cases. This demonstrated that the mater-
nal age effect in Down syndrome is limited to maternal nondisjunction and does 
not provide evidence for a comfortable selection against trisomic fetuses in older 
women [20, 21].
2. Sex-specific differences in meiosis
As discussed in many studies, studies of clinically recognized pregnancies indi-
cate that most human aneuploidy is of maternal origin. The question then arises: 
why is female meiosis so prone to error? In this section, we review oocyte develop-
ment and summarize the latest evidence that errors in the oocyte that predispose 
to chromosome misgrouping are increased, and that gender-specific differences 
in meiotic cell cycle checkpoints allow oocytes with these errors to develop into 
mature eggs [3, 22].
In mammals, meiotic recombination occurs in the fetal ovary and the signifi-
cance of the resulting physical connections for chromosome separation has been 
well observed. Studies in the 1990s identified transitions that could not be recom-
bined and / or optimally positioned as significant contributors to human trisomy.
Changing recombination is essential here. It is related to mother-derived 
trisomies as well as those originating from the father. However, the female is clearly 
at greater risk, as most aneuploidy occurs during oogenesis. Therefore, either more 
recombination errors are made in the female or these errors are removed more 
efficiently in the male [23, 24].
The immunofluorescence methodology has made it possible to examine cross-
linked proteins in pachytene spermatocytes and oocytes and thus test these alter-
natives. Interestingly, almost all chromosomes in males are joined by at least one 
crossover, but the same is not true for females [4, 14, 17].
Studies have shown that; The conclusion is that more than 10% of all human 
oocytes contain at least one “non-crossing” bivalent. Since half of all these divalent 
ones are expected to result in aneuploidy (Figure 2), the stage seems to have been 
adjusted for meiotic errors from the onset of oogenesis.
As suggested based on cytogenetic studies with no evidence of a difference in 
mean maternal age between maternal and paternal trisomy 21 cases. A factor asso-
ciated with aging of the oocyte therefore appears to be responsible for the maternal 
age effect in Down syndrome.
Among maternal errors, approximately 75% are considered errors in meiosis 
I and 25% as errors in meiosis II. Maternal meiosis I and II errors are linked to 
increased maternal age [25–27]. Two studies of cytogenetic short-arm heteromor-
phisms and microsatellite DNA polymorphisms showed inconsistencies regarding 
the meiotic period of non-separation and suggested pericentromeric increased 
recombination associated with nondisjunction. The place where chiasma occurs is 
the middle of the chromosome arm and then recombination is necessary for proper 
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chromosome separation as it holds the chromatids tightly and balances the attrac-
tion to opposite poles [28, 29].
Meiotic recombination was thought to stabilize matched homologs to ensure 
their proper separation. However, the process is stochastic and may not be handled 
properly even in euploid samples. Thus, achiasmate chromosomes are vulnerable 
to malsegregation and this condition gradually increases with age due to the rapid 
degradation of the protein mechanism within oocytes responsible for surveil-
lance and separation of chromosomes. A chiasma located near the telomere of the 
chromosome probably attaches the homolog to the spindle weaklier due to loss of 
cohesion and directs the kinetochore precisely towards the opposite pole. On the 
other hand, chiasmata close to the center occurs during MI, which causes chromo-
some entanglement so the bivalent cannot be separated correctly. In this way the 
MII can pass into the anaphase plate and then result in the reduction section; as a 
result, a disomic gamete is produced [30, 31].
Epidemiological studies have identified some environmental, habitual and 
socio-economic factors that may pose a risk for Ch21 NDJ. These can be observed in 
both MI and MII errors depending on maternal age or independent of maternal age. 
When we consider these findings, it is clear that Ch21 NDJ risk is a multifactorial 
event that interacts with genetic and environmental factors.
About 5% of trisomy 21 cases are likely due to the mitotic (postzygotic) non-
disjunction of chromosome 21 in the early embryo. This was demonstrated by the 
identification of pericentromeric DNA markers and the lack of recombination 
observed along the entire long arm of chromosome 21. Mitotic errors are not 
associated with advanced maternal age and do not show any preference depending 
on the parental origin of the replica chromosome 21. Mosaic with a normal cell line 
occurs in about 2–4% of newborns with Down syndrome. By DNA polymorphism 
analysis performed in 17 families with mosaic trisomy 21 probands, it showed that 
most cases were caused by a trisomic zygote with mitotic loss of one chromosome 
(Table 1) [32, 33].
Figure 2. 
Homogeneous due to meiotic non-disjunction.
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3. Changes in recombination
Failure to nondisjunction in maternal meiosis I is associated with reduced 
recombination between unallocated chromosomes 21, suggesting an important 
role for pairing / recombination errors or reduced recombination in the etiology of 
trisomy 21. Subsequent results showed an overall reduction in recombination, but 
with increased recombination in the distant region of 21q.
Origin Number of cases % Meiotic recombination
Maternal 732 90,7
MI 556 68,9 Reduced
MII 176 21,8 Increased
Paternal 44 5,5





MI: Meosis I, MII: Meosis II, Maternal and Paternal refer to parental origin of the chromosome that was 
duplicated by postzygotic nondisjunction
Table 1. 










Frequency of observed 
number recombinants
Frequency of the number 
inferred exchanges




175 0,70 0,20 0,10 0,47 0,32 0,21
Mid 
(29–34 yrs)
197 0,56 0,35 0,10 0,18 0,64 0,19
Old 
(>34 yrs)




58 — 0,66 0,34 — 0,22 0,78
Mid 
(29–34 yrs)
69 — 0,78 0,22 — 0,51 0,49
Old 
(>34 yrs)
126 — 0,81 0,19 — 0,57 0,44
Euploid
All Ages 152 0,52 0,39 0,09 0,20 0,50 0,30
Table 2. 
Frequency distribution of observed recombinants and inferred exchanges for each meiotic outcome group 
stratified by maternal age group [10].
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Unpredictably, nondisjunction in meiosis II is due to the increased recombi-
nation occurring in meiosis I suggesting that all errors are due to meiosis I. The 
recombination rate remains constant with advancing maternal age. However, 
possible chiasmate configurations of chromosome 21 appear more susceptible to 
nondisjunction in older oocytes than younger oocytes (Table 2).
Analysis of the chiasma configuration showed that the failure of a proximal 
recombination (or the presence of a telomeric recombination) tends to be nondis-
junction in meiosis I, while the presence of pericentromeric change appears to be 
nondisjunction in meiosis II [30, 31, 36, 37].
These findings are very effective in understanding the etiology of trisomy 21 and 
may explain why both maternal meiosis I and II errors are associated with increased 
maternal age. A two-hit nondisjunction model has been proposed where the first hit 
is the prenatal establishment of a sensitive tetrad and the second hit is the disrup-
tion of a meiotic process that increases the risk of nondisjunction of the susceptible 
configuration. The second hit can involve any element of the meiotic process and 
can be the basis for the maternal age effect. Recent studies have found signs indicat-
ing a reduction in the recombination rate in the total genome of eggs with chromo-
some 21 nondisjoined, meaning that the reduction in recombination is not limited 
to nondisjoined chromosomes but extends to other chromosomes as well [22].
The two-beat non-separation model needs to be validated with further study 
from other chromosomes and direct observation with oocytes.
4. Paternal nondisjunction
In the paternal nondisjunction of chromosome 21, there is mainly meiosis II 
error, as DNA polymorphisms show, in contrast to meiosis I errors and maternal 
nondisjunction.
Therefore, the mechanisms associated with paternal nondisjunction will likely 
differ from those associated with maternal nondisjunction.
In live births with Down syndrome; there is a well-known increasing ratio 
(about 1.15) between the sexes. This effect is limited to free trisomy 21 cases and 
does not include translocation-style trisomies, suggesting that increased sex ratio 
is associated with free trisomy 21 per se, not gender-based differential selection. 
As a result of molecular studies, it has been revealed that among the meiotic errors 
of the father, a rather high sex ratio (3.50) and male proband excess, in contrast to 
paternal mitotic errors and maternal errors, are specific to MII errors.
As with maternal meiosis, there is reduced recombination across the nondis-
joined 21. chromosome involved in the 22 paternal nondisjunction cases, but there 
is no difference in recombination between the 27 paternal MII cases compared to 
controls [14, 17, 34].
5. Recurrence risk of nondisjunction
Two molecular studies with families with free trisomy 21 relapse showed that 
mosaicism in parents is an important etiological factor and that this possibility 
alone may explain recurrent trisomy 21 in most families. In only a small number of 
families, the possibility of genetic predisposition for chromosomal nondisjunction 
could not be excluded [32, 35].
It has been previously shown that live born children with free trisomy 21 for 
chromosomally normal parents whose maternal age is less than 30 years have a 
significantly increased risk of recurrence [35].
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6. Risk factors
Many factors have been suggested as risk factors for nondisjunction in the past, 
but only in the last few studies identified the source of nondisjunction by DNA 
analysis. The increased frequency of the apolipoprotein E (APOE) allele Â4 was 
more observed in young mothers with MII errors in a population-scale study of 
Down syndrome in Denmark. This finding showed an increased risk of Alzheimer’s 
disease in a subgroup of young Down syndrome mothers and suggested the APOE 
E4 allele as a risk factor for nondisjunction in young mothers [36–38].
An association between an intron polymorphism in the presenilin-1 gene and 
maternal MII errors was identified in the same population-based study and the 
function of presenilin proteins in chromosome segregation was determined and 
thought to be related to subcellular localization.
Another population-based study revealed an association with young MII moth-
ers and maternal smoking and oral contraceptive use.
Both studies have found an association in young MII mothers, and the proposed 
risk factors support the ovarian risky microcirculation hypothesis to explain the 
effect of maternal age on nondisjunction, and it should not be overlooked.
Oocytes from hypoxic follicles under heavy exposure showed abnormalities in 
the organization of chromosomes on the metaphase spindle at high frequencies.
When we look at the two hit nondisjunction model, the findings suggest 
that aging alone is sufficient to disrupt the meiosis process, but there is a higher 
requirement for a genetic or environmental factor for nondisjunction to occur in 
young women.
A different recent study showed abnormal folate metabolism in mothers with 
Down syndrome; It was reported that the C677T mutation in the methylenetetra-
hydrofolate reductase (MTHFR) gene was higher in mothers with Down syndrome 
than in control mothers. However, the study included a small number of mothers 
and was not population-based, and so the source of nondisjunction could not be 
determined. Nevertheless, the study may support the at-risk microcirculation 
hypothesis as hyperhomocysteinemia is a known risk factor for vascular disease and 
the common MTHFR C677T mutation in the homozygous state is associated with 
mild hyperhomocysteinemia [39–42].
7. Conclusions
As a result, it shows that there is a high frequency of chromosome abnormali-
ties throughout embryonic development as a result of accumulated errors during 
gametogenesis and early mitotic divisions. Advancing female age is associated 
with increased rates of aneuploidy in oocytes and embryos. Especially during 
female meiosis, excessive chromosome losses, anaphase delay of chromosomes 
and / or capturing of the spindle by microtubules (congression failure) are impor-
tant mechanisms that cause aneuploidy during oogenesis and continue to have a 
significant effect during the first few mitotic divisions. Studies of abortions and 
molecular genetic analyzes of chromosomal abnormalities revealed that most 
aneuploidies occur during female meiosis, usually as a result of splitting in the first 
meiotic division. Aneuploidies and, to a lesser extent, male-meiotic errors due to 
both premature separation of sister chromatids during female meiotic divisions 
and mitotic chromosome malsegregation are quite common. The fact that aneu-
ploidies caused by these disturbances are rarely seen later in pregnancy increases 
the likelihood that the origin of aneuploidy may somehow affect the impact on 
embryo viability.
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While interest in the development and refinement of culture systems to support 
the development of functional gametes from stem cells for the treatment of infertil-
ity has been intense, so far those working in these areas have shown little interest 
in the meiotic process. Obviously, the successful production of normal gametes in 
vitro will require great attention to meiotic details and a full understanding of the 
differences between the sexes.
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PCR Polymerase chain reaction
SSR Microsatellites or simple sequence repeat
STR Short tandem repeat
APOE Apolipoprotein E
MTHFR Methylenetetrahydrofolate reductase.
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